Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study Assessing KB304 for the Treatment of Wrinkles in Women
Sponsor: Krystal Biotech, Inc.
Summary
The aim of this study is to investigate the safety and efficacy of KB304, an investigational gene therapy to correct moderate to severe wrinkles in the décolleté region (V-shaped chest area). KB304 is an investigational gene therapy that delivers functional, full-length human collagen (COL3) and elastin (tropoelastin) to the skin through small injections using the Sponsor's genetically engineered Herpes Simplex Virus (HSV-1) vector. The study is a randomized double-blind study and participants will receive either KB304 (active group) or placebo (inactive group).
Official title: A Phase 1/2 Study of KB304, a Replication-Defective, Non-Integrating Vector Expressing Human Type III Collagen (COL3) and Tropoelastin for the Treatment of Wrinkles
Key Details
Gender
FEMALE
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
19
Start Date
2024-11-20
Completion Date
2025-08
Last Updated
2025-05-13
Healthy Volunteers
Yes
Interventions
KB304
Genetically modified herpes simplex type 1 virus
0.9% Normal Saline (NS)
Placebo
Locations (1)
Steve Yoelin Medical Associates
Newport Beach, California, United States